Mr. Stapley has deep experience in the genomic diagnostics industry, including significant expertise building and leading complex global operations.

Rob Brainin is a seasoned professional with over 20 years of executive life sciences and healthcare experience, and a proven track record of using emerging technologies and data science to improve healthcare.

Rebecca Chambers has extensive healthcare leadership experience, previously serving as Chief Financial Officer for Outset Medical, a publicly traded medical technology company focused on reducing dialysis cost and complexity.

Corinne Danan serves as Veracyte’s General Manager, Biopharma, leading the company’s offerings to biopharmaceutical companies. Ms. Danan brings more than 30 years of executive experience in the pharmaceutical, life sciences and healthcare industries, as well as strong leadership in Commercial Operations, to her role at Veracyte.

Mr. French brings more than 20 years of information and operational leadership experience in the life sciences and technology industries.

Fabienne Hermitte, Ph.D., brings deep expertise in clinical diagnostics to her role at Veracyte. She cofounded HalioDx, an immuno-oncology diagnostics company, in 2015. At HalioDx, she led the Regulatory, Quality, Medical Affairs, Clinical Development and Diagnostic Marketing teams prior to the company’s acquisition by Veracyte in August 2021.

Dr. Leite joined Veracyte in September 2022, bringing with him deep diagnostics industry leadership experience. Previously, he served as Chief Business Officer for InterVenn Biosciences, a private-stage diagnostics company, where he was responsible for the company’s commercial, partnership and market access strategy.

Annie McGuire joined Veracyte in February 2022 as Executive Vice President, General Counsel and Chief People Officer, overseeing all aspects of the company’s legal functions.

Tracy leads the strategy to enhance and extend the global company’s narrative and brand. She oversees integrated marketing communications, public relations and digital marketing to advance the company’s industry leadership and support its business objectives.

Tina S. Nova, Ph.D., serves as General Manager, Decipher Urologic Cancers. In this role, she leads all aspects – market development, product marketing, reimbursement, sales and lab operations – of the company’s broad menu of diagnostic tests that are performed in its laboratories, serving physicians and their patients in the United States.

Jonathan Wygant joined Veracyte in February 2022 as Vice President and Chief Accounting Officer, overseeing all aspects of the company’s global accounting operations, financial reporting and tax functions.